Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 15, 2021, titled "ALKEM launches Brivaracetam in India under the brand name Brivasure for treatment of Epilepsy".
Press Release Mar 15 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Alkem Laboratories Ltd. on 6ix
Earlier from Alkem Laboratories
Later from Alkem Laboratories
- Press Release Mar 23 2021
- Press Release Jun 10 2021
- Press Release (Revised) Jun 10 2021
- Press Release Jun 19 2021
- Press Release Jul 29 2021
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories